Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Setting Up a Risk Management Program for Aerosol Production – V 2.0

Posted on By

Aerosol: SOP for Setting Up a Risk Management Program for Aerosol Production – V 2.0

SOP for Setting Up a Risk Management Program for Aerosol Production

Department Aerosol
SOP No. SOP/Aerosol/169/2025
Supersedes SOP/Aerosol/169/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a risk management program for aerosol production. This program aims to identify, assess, and mitigate risks associated with manufacturing, ensuring product quality, worker safety, and regulatory compliance.

2. Scope

This SOP applies to all aerosol manufacturing operations, including raw material handling, formulation, filling, packaging, storage, and distribution. It encompasses risk identification, evaluation, mitigation, and documentation.

3. Responsibilities

  • Risk Management Team: Responsible for implementing and overseeing the risk management program.
  • Quality Assurance (QA) Team: Responsible for monitoring compliance with risk mitigation measures.
  • Production Team: Responsible for identifying operational risks and reporting potential hazards.
  • Engineering and Maintenance Team: Responsible for evaluating equipment-related risks and ensuring proper maintenance.
  • Regulatory Affairs Team: Responsible for ensuring risk management practices align with regulatory requirements.
See also  Aerosol: SOP for Quality Check During Propellant Filling - V 2.0

4. Accountability

The Risk Management Program is overseen by the QA Manager, who is accountable for ensuring risk assessment activities are conducted and documented as per this SOP.

5. Procedure

5.1. Risk Identification

  1. Define risk categories, including:
    • Operational Risks: Equipment failure, human error, process deviations.
    • Quality Risks: Raw material variability, contamination, out-of-specification (OOS)
results.
  • Safety Risks: Fire hazards, chemical exposure, explosion risks.
  • Regulatory Risks: Non-compliance with GMP and local regulations.
  • Conduct brainstorming sessions and hazard identification workshops to capture potential risks.
  • Use risk identification tools such as Process Flow Analysis and Failure Mode and Effects Analysis (FMEA).
  • 5.2. Risk Assessment

    1. Assess risks based on severity, likelihood, and detectability.
    2. Use a Risk Assessment Matrix (Annexure-1) to prioritize risks.
    3. Assign risk ratings as:
      • Low Risk: No immediate action required, routine monitoring.
      • Medium Risk: Requires corrective actions and ongoing monitoring.
      • High Risk: Immediate corrective action and mitigation plan required.

    5.3. Risk Mitigation

    1. Develop risk control strategies, including:
      • Process modifications to eliminate hazards.
      • Engineering controls such as ventilation systems and automated equipment.
      • Procedural controls, including revised SOPs and enhanced training.
      • Personal Protective Equipment (PPE) requirements.
    2. Implement mitigation measures and document them in the Risk Mitigation Plan (Annexure-2).
    3. Assign responsibility for each risk control measure and track progress.

    5.4. Risk Monitoring and Review

    1. Establish monitoring procedures to track the effectiveness of mitigation actions.
    2. Conduct periodic risk reviews and update risk assessments as needed.
    3. Maintain records of risk assessments and mitigation actions in the Risk Register (Annexure-3).

    5.5. Risk Communication

    1. Ensure all relevant personnel are informed about identified risks and mitigation measures.
    2. Conduct training sessions on risk awareness and prevention.
    3. Communicate critical risks to senior management and regulatory bodies when necessary.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • FMEA: Failure Mode and Effects Analysis
    • PPE: Personal Protective Equipment
    • OOS: Out-of-Specification

    7. Documents

    1. Risk Assessment Matrix (Annexure-1)
    2. Risk Mitigation Plan (Annexure-2)
    3. Risk Register (Annexure-3)

    8. References

    • Good Manufacturing Practice (GMP) Guidelines
    • ISO 31000 – Risk Management Standard
    • FDA Risk-Based Approach to Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Risk Assessment Matrix

    Risk ID Risk Description Severity Likelihood Risk Rating Action Required
    RISK-001 Valve failure during filling High Likely High Implement preventive maintenance

    Annexure-2: Risk Mitigation Plan

    Risk ID Mitigation Strategy Responsible Person Implementation Date Status
    RISK-001 Increase valve inspection frequency Maintenance Manager 10/02/2025 Ongoing

    Annexure-3: Risk Register

    Risk ID Risk Category Mitigation Actions Status
    RISK-001 Equipment Failure Routine checks added Active

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
    01/01/2025 V 2.0 Updated risk categories GMP Compliance Anjali Sharma
    See also  Aerosol: SOP for Documenting Change Control Activities - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Biosimilars: SOP for Use of Single-Use Bioreactor Systems – V 2.0
    Next Post: Elixir Department: SOP for Use of Inline Filters During Manufacturing – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version